Patent Assignment
Reel/Frame 062287/0841
Assignment of Assignor's Interest
Recorded: 2023-01-05
Pages: 6
Assignor
TAURUS DEVELOPMENT COMPANY LLC
Executed: 2022-11-18
Assignee
PARK THERAPEUTICS, INC.
2031 US HIGHWAY 130, MONMOUTH JUNCTION, NEW JERSEY, 08852
Covered Properties
(3)
Calcitonin Products and Therapies for Treating Inflammatory or Degenerative Diseases
Room Temperature Stable Oral Calcitonin Formulation
Room Temperature Stable Oral Calcitonin Formulation
Related Assignments
(15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 22, 2016
From: UGP THERAPEUTICS, INC.
To: TARSA THERAPEUTICS, INC.
Reel/Frame 038350/0467 →
Assignment of Assignor's Interest
Apr 22, 2016
From: UNIGENE LABORATORIES, INC.
To: UGP THERAPEUTICS, INC.
Reel/Frame 038350/0457 →
Assignment of Assignor's Interest
Apr 22, 2016
From: MEHTA, NOZER M.; GILLIGAN, JAMES P.
To: UNIGENE LABORATORIES INC.
Reel/Frame 038350/0427 →
Security Interest
Jun 30, 2016
From: TARSA THERAPEUTICS, INC.
To: OXFORD FINANCE LLC
Reel/Frame 039056/0419 →
Assignment of Assignor's Interest
Nov 26, 2018
From: TARSA THERAPEUTICS, INC.
To: TAURUS DEVELOPMENT COMPANY LLC
Reel/Frame 047580/0917 →
Assignment of Assignor's Interest
Aug 16, 2019
From: GILLIGAN, JAMES P.; MAURER, GEORGE R.; RAILKAR, ANIRUDDHA M.; BAUER, PHIL
To: TARSA THERAPEUTICS, INC.
Reel/Frame 050072/0389 →
Assignment of Assignor's Interest
Aug 16, 2019
From: DAGGS, THOMAS A.; SHIELDS, PAUL P.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 050072/0341 →
Assignment of Assignor's Interest
Aug 16, 2019
From: TARSA THERAPEUTICS, INC.
To: TAURUS DEVELOPMENT COMPANY LLC
Reel/Frame 050072/0425 →
Security Interest
Aug 26, 2019
From: ENTERIS BIOPHARMA, INC.
To: CADENCE BANK, N.A.
Reel/Frame 050174/0428 →
Assignment of Assignor's Interest
Feb 18, 2022
From: TARSA THERAPEUTICS, INC.
To: TAURUS DEVELOPMENT COMPANY LLC
Reel/Frame 059051/0340 →
Assignment of Assignor's Interest
Feb 18, 2022
From: GILLIGAN, JAMES P.; MAURER, GEORGE R.; RAILKAR, ANIRUDDHA M.; BAUER, PHIL
To: TARSA THERAPEUTICS, INC.
Reel/Frame 059051/0297 →
Assignment of Assignor's Interest
Feb 18, 2022
From: DAGGS, THOMAS A.; SHIELDS, PAUL P.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 059051/0284 →
Release of Security Interest
Jun 28, 2023
From: CADENCE BANK, A MISSISSIPPI BANK AND SUCCESSOR BY MERGER TO CADENCE BANK, N.A., A NATIONAL BANKING ASSOCIATION, AS AGENT
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 064149/0741 →
Security Interest
Sep 26, 2024
From: TRIS PHARMA, INC.; PARK THERAPEUTICS, INC.
To: PROVIDENT BANK
Reel/Frame 069065/0576 →
Corrective Assignment to Correct the the Assignment Previously Recorded Previously Recorded at Reel: 068713 Frame: 0499. Assignor(S) Hereby Confirms the Assignment.
Oct 24, 2024
From: TRIS PHARMA, INC.; PARK THERAPEUTICS, INC.
To: PROVIDENT BANK
Reel/Frame 070760/0864 →